ProQR Therapeutics NV
NASDAQ:PRQR

Watchlist Manager
ProQR Therapeutics NV Logo
ProQR Therapeutics NV
NASDAQ:PRQR
Watchlist
Price: 3.62 USD 0.28% Market Closed
Market Cap: 383.4m USD
Have any thoughts about
ProQR Therapeutics NV?
Write Note

Wall Street
Price Targets

PRQR Price Targets Summary
ProQR Therapeutics NV

Wall Street analysts forecast PRQR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRQR is 6.83 USD with a low forecast of 2.17 USD and a high forecast of 14.7 USD.

Lowest
Price Target
2.17 USD
40% Downside
Average
Price Target
6.83 USD
89% Upside
Highest
Price Target
14.7 USD
306% Upside

PRQR Last Price Targets
ProQR Therapeutics NV

The latest public price target was made on Mar 14, 2024 by Keay Nakae from Loop Capital Markets , who expects PRQR stock to drop by 31% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Keay Nakae
Loop Capital Markets
2.5 USD
Downside 31%
8 months ago
Mar 14, 2024
ProQR Therapeutics N.V. (PRQR) PT Raised to $2.50 at Chardan Capital Markets
StreetInsider
Keay Nakae
Loop Capital Markets
Price Target 2.5 USD
Upside/Downside 31%
View Source
ProQR Therapeutics NV Competitors:
Price Targets
AGIO
Agios Pharmaceuticals Inc
1% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
14% Downside
SOBI
Swedish Orphan Biovitrum AB (publ)
31% Upside
PYC
PYC Therapeutics Ltd
77% Upside
688278
Xiamen Amoytop Biotech Co Ltd
3% Upside
ALKS
Alkermes Plc
20% Upside
300896
Imeik Technology Development Co Ltd
39% Upside
4891
TMS Co Ltd
278% Upside

Revenue
Forecast

Revenue Estimate
ProQR Therapeutics NV

For the last 8 years the compound annual growth rate for ProQR Therapeutics NV's revenue is 14%. The projected CAGR for the next 3 years is 18%.

14%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ProQR Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

Net Income
Forecast

Net Income Estimate
ProQR Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-61%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRQR's stock price target?
Price Target
6.83 USD

According to Wall Street analysts, the average 1-year price target for PRQR is 6.83 USD with a low forecast of 2.17 USD and a high forecast of 14.7 USD.

What is ProQR Therapeutics NV's Revenue forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for ProQR Therapeutics NV's revenue is 14%. The projected CAGR for the next 3 years is 18%.

Back to Top